Main description:

Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.

Contents:

Innovation: Key to Success in the Pharmaceutical Industry.- The Industry Challenge: Who Would Want to Be in This Business?- The Science and Technology Challenge: How to Find New Drugs.- The Pipeline Challenge: How to Organize Innovation.- The Make-or-Buy Challenge: How to In- and Outsource Innovation.- The Open Innovation Challenge: How to Partner for Innovation.- The Internationalization Challenge: Where to Access Innovation.- Future Directions and Trends.